News & Research

Scientific updates, journal club and international perspective.

Items are included for professional information. Inclusion does not constitute endorsement by the Institute. Source types are identified so that company, industry and commentary material is not presented as equivalent to peer-reviewed research.

CommentaryAugust 2026

Analysis of the DEA post-hearing brief on proposed Schedule III placement

A specialist regulatory publication discusses the DEA filing. This is commentary on an ongoing process, not a final regulatory decision.

Read →
Industry newsAugust 2026

German medical cannabis reimbursement proposals face regulatory disagreement

Industry reporting describes disagreement concerning proposed reimbursement and insurance arrangements in Germany; it is not an official regulatory statement.

Read →
Peer-reviewed studyAugust 2026

Phase 3 trial reports outcomes for a standardised cannabis extract in chronic low back pain

A randomised, placebo-controlled trial studied a defined, standardised cannabis extract in adults with chronic low back pain. Findings should not be generalised to other products, formulations, indications or populations.

Read →
University announcementMay 2026

University reports cannabidiol trial findings in people with nerve-injury pain

The announcement concerns a defined cannabidiol intervention and a particular nerve-injury population; it does not establish effects for all cannabis products or pain conditions.

Read →
Regulatory updateFebruary 2026

TGA responds to review of Australian medicinal cannabis access pathways

The Australian regulator outlines its response to a review of unapproved medicinal cannabis products and current access pathways.

Read →
Company announcementAugust 2026

Medical cannabis producer reports cultivation capacity expansion and comments on German regulatory guidance

A company update concerning production capacity and the German market. Company announcements are identified separately from independent research and regulatory sources, and do not constitute product promotion.

Read →